Impact of NA‐1 on Pericyte‐Driven Vasoconstriction and Its Role in No‐Reflow During Cerebral Ischemia–Reperfusion

Authors:

Abstract
Background: The no‐reflow phenomenon in the ischemic brain following arterial recanalization leads to poor prognosis. Previous studies suggest that the clinically proven NA‐1 drug, with disruption of PSD95 in the neuronal terminals alongside the cerebral microvasculature, may inhibit pericytic contraction of microvessels by reducing endothelin‐1 secretion.Methods: A 1.5‐h tMCAO model using Balb/c mice was employed. In vivo two‐photon imaging and immunofluorescence staining were employed to assess the constriction effect of pericytes on capillaries. The impact of NR2B9c/NA‐1 administration (intravenously infused at a dose of 10 μmol/kg) on pericyte constriction was evaluated through immunofluorescent staining of brain sections. Additionally, The effect of NA‐1 on cerebral perfusion was assessed using laser speckle blood flow monitoring, whole brain slice perfusion, and high‐magnification capillary imaging. Enzyme‐linked immunosorbent Assay (ELISA) was conducted to determine changes in quantitative ONOO− and endothelin‐1 (ET‐1) content after tat‐NA‐1 administration. Lastly, microtubule‐associated protein 2 (MAP2) staining and behavioral scores were used to evaluate the effects of NA‐1 on infarct size and behavioral deficits.Results: In vivo two‐photon imaging and immunofluorescence staining revealed that pericyte constriction following ischemia and recanalization resulted in a decreased diameter of capillaries, particularly at the soma and adjacent areas. Notably, capillary obstruction was localized near pericytes. After administration of NA‐1, the immunofluorescence staining section showed that the diameter of capillaries at pericytes' soma and in the adjacent parts increased. The ELISA results indicated a reduction in ONOO− and ET‐1 levels. Additionally, MAP2 staining revealed a decrease in infarct size, while behavioral scores showed improvements in deficits. This effect of NA‐1 was counteracted notably when added ET‐1.Conclusion: NA‐1 inhibits pericyte constriction following ischemia–reperfusion by reducing ET‐1 levels. It improves capillary no‐reflow in mice, enhances cerebral perfusion, decreases infarct size, and mitigates behavioral deficits.
Funding Information
  • National Natural Science Foundation of China (81820108012, 82001920, 82071301)